首页 | 本学科首页   官方微博 | 高级检索  
     

CD133在子宫内膜癌中的研究进展
引用本文:梅彤,舒宽勇. CD133在子宫内膜癌中的研究进展[J]. 中国计划生育和妇产科, 2012, 0(4): 77-80
作者姓名:梅彤  舒宽勇
作者单位:南昌大学研究生院医学部;江西省妇幼保健院肿瘤科
摘    要:女性生殖道恶性肿瘤严重危及女性健康,子宫内膜癌(endometrial cancer,EC)占妇科恶性肿瘤的20%~30%。同其他恶性肿瘤一样具有侵袭和转移的特性,且远处转移是影响其预后的重要因素。目前提出的"肿瘤干细胞理论"认为,子宫内膜癌肿瘤组织中也存在少量具有自我更新、无限分化和增殖的肿瘤干细胞,这些干细胞可能是子宫内膜癌发生、转移和复发的关键。CD133作为一个公认的新型肿瘤干细胞的标记物在多种肿瘤组织中表达,同样也有望成为子宫内膜癌干细胞的特异性标记物及评估子宫内膜癌预后的有效标记物。

关 键 词:肿瘤干细胞  CD133  子宫内膜癌

Research progress of CD133 in endometrial cancer
MEI Tong,SHU Kuan-yong. Research progress of CD133 in endometrial cancer[J]. , 2012, 0(4): 77-80
Authors:MEI Tong  SHU Kuan-yong
Affiliation:1.Medical Department of Graduate School,Nanchang University,Nanchang Jiangxi 330006,P.R.China;2.Department of Oncology,Maternal and Child Health Hospital of Jiangxi,Nanchang Jiangxi 330006,P.R.China
Abstract:The tumor of female genital tract is a serious threat to women’s health,and endometrial cancer(EC) accounted for 20%~30%.Like other malignant tumors,EC has features of invasion and metastasis,which affects patients’ prognosis.The theory of cancer stem cells(CSCs) has suggested that there be a small amount of CSCs with the capacity of self-renewal,differentiation and proliferation in EC tissues.These stem cells may be the key of EC’s occurrence,metastasis and recurrence.CD133,as a new marker of CSCs in various tumor tissues,would be expected to become specific marker of endometrial cancer stem cells(ECSCs) and effectively assess the prognosis.
Keywords:cancer stem cells  CD133  endometrial cancer
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号